Optimal Stenting in Saphenous Vein Graft Intervention

Gabriel Maluenda; Augusto D Pichard

doi:10.1016/j.iccl.2012.11.006

Optimal Stenting in Saphenous Vein Graft Intervention

Interv Cardiol Clin. 2013 Apr;2(2):307-313. doi: 10.1016/j.iccl.2012.11.006. Epub 2013 Jan 17.

Authors

Gabriel Maluenda¹, Augusto D Pichard²

Affiliations

¹ Division of Cardiology, Department of Internal Medicine, Washington Hospital Center, 110 Irving Street, Northwest, Suite 4B-1, Washington, DC 20010, USA.
² Division of Cardiology, Department of Internal Medicine, Washington Hospital Center, 110 Irving Street, Northwest, Suite 4B-1, Washington, DC 20010, USA. Electronic address: Augusto.D.Pichard@medstar.net.

PMID: 28582137
DOI: 10.1016/j.iccl.2012.11.006

Abstract

Percutaneous interventions of (usually degenerated) saphenous vein grafts (SVG) are associated with higher risk of distal embolization and worse clinical outcomes, including target vessel revascularization, myocardial infarction, and death, as compared with percutaneous coronary intervention of native coronary arteries. Embolic protection devices have demonstrated value in reducing the risk of embolization and postprocedural enzyme elevation after SVG interventions. Frequently, however, such devices are not used or cannot be used. As a result, novel stenting strategies intended to decrease the risk of periprocedural myocardial infarction seem to play a major role in enhancing the results following SVG interventions.

Keywords: Clinical outcomes; Percutaneous coronary intervention; Saphenous vein graft; Stenting.

Publication types

Review